Citadel Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.9M Sell
622,760
-744,699
-54% -$17.8M 0.01% 2784
2025
Q4
$36.5M Buy
1,367,459
+1,043,939
+323% +$24.9M 0.02% 1721
2025
Q3
$6.9M Sell
323,520
-2,689,176
-89% -$63.6M 0.01% 3815
2025
Q2
$65M Buy
3,012,696
+2,718,036
+922% +$50.5M 0.06% 1035
2025
Q1
$4.89M Sell
294,660
-43,205
-13% -$785K ﹤0.01% 3908
2024
Q4
$6.2M Buy
337,865
+170,303
+102% +$2.75M 0.01% 3629
2024
Q3
$2.58M Sell
167,562
-486,206
-74% -$8.11M ﹤0.01% 5047
2024
Q2
$10.6M Buy
653,768
+84,510
+15% +$1.36M 0.01% 2696
2024
Q1
$10.5M Buy
569,258
+416,224
+272% +$10.3M 0.01% 2888
2023
Q4
$4.79M Buy
153,034
+147,625
+2,729% +$3.53M ﹤0.01% 3858
2023
Q3
$113K Sell
5,409
-17,792
-77% -$483K ﹤0.01% 10741
2023
Q2
$556K Sell
23,201
-80,482
-78% -$1.79M ﹤0.01% 7714
2023
Q1
$1.95M Sell
103,683
-116,075
-53% -$2.21M ﹤0.01% 5430
2022
Q4
$3.5M Sell
219,758
-189,521
-46% -$2.96M ﹤0.01% 4500
2022
Q3
$6.7M Buy
409,279
+109,982
+37% +$1.78M 0.01% 3394
2022
Q2
$4.22M Sell
299,297
-117,641
-28% -$2.2M 0.01% 4124
2022
Q1
$10.1M Buy
416,938
+178,263
+75% +$4.31M 0.01% 2943
2021
Q4
$5.57M Sell
238,675
-545,416
-70% -$11M 0.01% 4108
2021
Q3
$13M Buy
784,091
+650,085
+485% +$12.5M 0.01% 2627
2021
Q2
$3.27M Sell
134,006
-95,048
-41% -$2.15M ﹤0.01% 5394
2021
Q1
$5.91M Sell
229,054
-1,043,975
-82% -$46M 0.01% 3900
2020
Q4
$68.1M Sell
1,273,029
-1,296,722
-50% -$64.4M 0.08% 758
2020
Q3
$106M Sell
2,569,751
-1,296,132
-34% -$56M 0.14% 432
2020
Q2
$187M Buy
3,865,883
+164,528
+4% +$7.9M 0.26% 198
2020
Q1
$156M Buy
3,701,355
+1,076,658
+41% +$44.4M 0.24% 193
2019
Q4
$112M Buy
2,624,697
+710,106
+37% +$30.9M 0.14% 346
2019
Q3
$68.9M Buy
1,914,591
+150,837
+9% +$4.57M 0.09% 578
2019
Q2
$47.1M Sell
1,763,754
-12,586
-0.7% -$322K 0.06% 759
2019
Q1
$47.7M Sell
1,776,340
-1,062,582
-37% -$24.8M 0.06% 712
2018
Q4
$45.9M Buy
2,838,922
+359,302
+14% +$6.98M 0.07% 674
2018
Q3
$51.5M Buy
2,479,620
+2,389,582
+2,654% +$37.6M 0.06% 743
2018
Q2
$1.38M Buy
90,038
+48,958
+119% +$873K ﹤0.01% 4681
2018
Q1
$923K Sell
41,080
-37,512
-48% -$1.04M ﹤0.01% 4942
2017
Q4
$2.37M Buy
78,592
+1,380
+2% +$44.1K ﹤0.01% 3396
2017
Q3
$2.91M Buy
77,212
+61,920
+405% +$2.01M ﹤0.01% 2966
2017
Q2
$426K Sell
15,292
-1,388
-8% -$41.4K ﹤0.01% 5347
2017
Q1
$573K Sell
16,680
-455,272
-96% -$16.1M ﹤0.01% 4805
2016
Q4
$13.6M Buy
471,952
+447,580
+1,836% +$11.8M 0.03% 1132
2016
Q3
$775K Buy
+24,372
New +$826K ﹤0.01% 4170
2016
Q2
Sell
-59,717
Closed -$2M 6759
2016
Q1
$1.67M Sell
59,717
-1,069,218
-95% -$23.3M ﹤0.01% 2847
2015
Q4
$40.2M Sell
1,128,935
-111,184
-9% -$3.92M 0.07% 487
2015
Q3
$41M Buy
1,240,119
+1,104,287
+813% +$45.9M 0.06% 523
2015
Q2
$5.69M Sell
135,832
-76,120
-36% -$2.95M 0.01% 1932
2015
Q1
$6.91M Sell
211,952
-684,603
-76% -$23.5M 0.01% 1715
2014
Q4
$28.5M Buy
896,555
+248,861
+38% +$7.06M 0.05% 750
2014
Q3
$16M Buy
647,694
+290,574
+81% +$6.8M 0.03% 1044
2014
Q2
$8.07M Buy
357,120
+317,364
+798% +$6.63M 0.02% 1437
2014
Q1
$967K Buy
39,756
+30,246
+318% +$765K ﹤0.01% 3469
2013
Q4
$238K Sell
9,510
-14,176
-60% -$334K ﹤0.01% 4844
2013
Q3
$651K Sell
23,686
-51,573
-69% -$1.08M ﹤0.01% 3537
2013
Q2
$1.37M Buy
+75,259
New +$1.04M ﹤0.01% 2867

Other funds holding ACAD